Page last updated: 2024-11-02

palmidrol and Atrophy

palmidrol has been researched along with Atrophy in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Argenio, G1
Petrosino, S1
Gianfrani, C1
Valenti, M1
Scaglione, G1
Grandone, I1
Nigam, S1
Sorrentini, I1
Mazzarella, G1
Di Marzo, V1

Other Studies

1 other study available for palmidrol and Atrophy

ArticleYear
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
    Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Cas

2007